Koers Aegerion Pharmaceuticals, Inc.

Aandelen

Vertraagde tijd Nasdaq Andere beurzen 22:00:00 29-11-2016			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
1,97 ^USD	+5,35%		+4,23%	-80,50%

Duur

Periode

Stijl

Aegerion Pharmaceuticals, Inc. and QLT Inc. Complete Merger Transaction; QLT to Change Name to Novelion Therapeutics Inc.	29-11-16
Aegerion Pharmaceuticals’ JUXTAPID® (lomitapide) Capsules for the Treatment of Homozygous Familial Hypercholesterolemia (HoFH) Receives Pricing Authorization in Japan	17-11-16
Aegerion Pharmaceuticals Announces Third Quarter 2016 Financial Results	03-11-16
Aegerion Pharmaceuticals : Research Reports Coverage on Biotech Stocks -- Merrimack Pharma, Aurinia Pharma, Aegerion Pharma, and TG Therapeutics	24-10-16
Aegerion Pharmaceuticals' : JUXTAPID® (lomitapide) Capsules Approved in Japan for the Treatment of Homozygous Familial Hypercholesterolemia (HoFH)	28-09-16

1 dag

+5,35%

Managers	Titel	Leeftijd	Van
Sheila Frame PSD	President	62	-
Elizabeth Jobes BRD	Director/Board Member	57	-
Ailish Hogan SEC	Corporate Secretary	-	-

Besturend	Titel	Leeftijd	Van
Sheila Frame PSD	President	62	-
Elizabeth Jobes BRD	Director/Board Member	57	-

Sector